BamSEC and AlphaSense Join Forces
Learn More

Juno Therapeutics, Inc.

Formerly NASDAQ: JUNO
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.34E
from 10-K 4 pages October 6, 2017 Celgene Corporation 86 Morris Avenue Summit, Nj 07901 Attention: Robert Hershberg, MD, Phd, Executive Vice President Business Development and Global Alliances Re: Consent Under Section 2.2.8 of the License Agreement by and Among Celgene Corporation, Celgene Switzerland LLC (Together With Celgene Corporation, “Celgene”), and Juno Therapeutics, Inc. (“JUNO”), Dated as of April 22, 2016 (“License Agreement”) Dear Rob
12/34/56
EX-10.31F
from 10-K 13 pages Fifth Amendment to Lease Agreement
12/34/56
EX-10.31E
from 10-K ~10 pages Fourth Amendment to Lease Agreement
12/34/56
EX-10.29
from 10-K ~5 pages Material contract
12/34/56
EX-10.23G
from 10-K ~10 pages Juno Therapeutics, Inc. 2014 Equity Incentive Plan Restricted Stock Unit Award Agreement Notice of Grant of Restricted Stock Units
12/34/56
EX-10.1
from 8-K 6 pages [Name] Re: Tax Reimbursement Agreement to [•]
12/34/56
EX-10.1
from 8-K 20 pages Juno Therapeutics, Inc. 2014 Equity Incentive Plan Restricted Stock Agreement Notice of Grant of Restricted Stock
12/34/56
EX-10.1
from 8-K 27 pages Share Purchase Agreement and Omnibus Amendment
12/34/56
EX-10.2
from 10-Q 4 pages April 13, 2017 Dr. Sunil Agarwal [Omitted] Delivered in Person
12/34/56
EX-10.1B
from 10-Q 2 pages Amendment No. 3 to Sponsored Research Agreement
12/34/56
EX-10.1A
from 10-Q 13 pages Amendment No. 2 to Sponsored Research Agreement
12/34/56
EX-10.2B
from 10-Q 3 pages Second Amendment to Sublease
12/34/56
EX-10.2A
from 10-Q 6 pages First Amendment to Sublease
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to Sublease
12/34/56
EX-10.39
from 10-K 5 pages Juno Therapeutics, Inc. Independent Contractor Agreement
12/34/56
EX-10.31D
from 10-K 21 pages Third Amendment to Lease Agreement
12/34/56
EX-10.23E
from 10-K 12 pages Juno Therapeutics, Inc. 2014 Equity Incentive Plan Restricted Stock Unit Award Agreement Notice of Grant of Restricted Stock Units
12/34/56
EX-10.4
from 10-Q 1 page May 27, 2016 Dear Hy: This Letter Amends and Supplements Your May 27, 2015, Letter (“Offer Letter”) From Juno Therapeutics, Inc. (“Company”). the Fifth Paragraph of the Offer Letter (Beginning “You Will Be Expected to Base Your Employment . . . .”) Is No Longer in Effect and Is Replaced by the Following Three Paragraphs
12/34/56
EX-10.3
from 10-Q 4 pages Amendment No. 1 to Exclusive License Agreement
12/34/56
EX-10.2
from 10-Q 71 pages License Agreement by and Among Juno Therapeutics, Inc. and Celgene Corporation and Celgene Switzerland LLC Dated as of April 22, 2016
12/34/56